1. Thailand Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Vibhavadi Medical Center Public Co. Ltd.

Vibhavadi Medical Center Public Co. Ltd.

1.32
THB
0.00
(0.00%)
0.15EPS
10.00P/E
18.47BMarket Cap
Nov 18Next Earn
Vibhavadi Medical Center Public Co. Ltd.
SET:VIBHA
(Stock Exchange of Thailand)

Recent

price

1.32

P/E

ratio

10.00

div

yld

8.16%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
THB
0.17
0.18
0.32
0.39
0.39
0.43
0.45
0.46
0.49
0.5
0.45
0.54
0.63
0.6
0.43
0.42
0.31
Revenue per Share
0.02
0.02
0.03
0.05
0.05
0.06
0.05
0.07
0.05
0.06
0.03
0.13
0.1
0.06
0.05
0.13
0.14
Basic EPS, GAAP
0.02
0.01
0.05
0.05
0.03
0.05
-0.01
0.02
0.05
0.01
-0.03
0.05
0.11
0.1
0.09
0.03
0.03
Free Cash Flow per Basic Share
0.01
0.02
0.02
0.03
0.03
0.04
0.03
0.04
0.04
0.05
0.05
0.05
0.06
0.07
0.06
0.1
0.11
Dividend per Share
0.18
0.25
0.29
0.34
0.39
0.42
0.52
0.53
0.54
0.59
0.6
0.9
1.06
0.95
0.85
0.86
0.85
Book Value per Share
0.18
0.21
0.23
0.28
0.33
0.36
0.46
0.48
0.48
0.53
0.55
0.84
1.01
0.89
0.79
0.84
0.82
Tangible Book Value per Share
8,379
8,653
12,417
11,475
12,577
12,585
12,721
13,169
13,197
13,214
13,414
13,576
13,576
13,576
13,523
13,485
13,485
Basic Weighted Avg Shares
1,403
1,597
3,970
4,515
4,884
5,396
5,740
6,102
6,474
6,546
6,024
7,373
8,612
8,173
5,808
5,617
4,169
Sales/Revenue/Turnover
12.71
11.54
15.89
18.21
17.45
19.84
18.03
17.77
15.89
14.21
12.2
18.54
20.51
15.87
14.59
15.41
14.71
Operating Margin (%)
120
124
258
294
319
338
370
397
413
413
439
501
625
647
641
617
520
Depreciation Expense
161
135
392
546
596
736
679
869
724
809
465
1,805
1,340
865
699
1,695
1,847
Net Income, GAAP
24.63
31.78
23.13
18.13
18.07
18.33
20.63
15.57
17.77
17.21
18.72
10.14
15.46
15.48
14.1
3.13
4.12
Effective Tax Rate (%)
11.46
8.46
9.86
12.1
12.21
13.63
11.82
14.23
11.18
12.36
7.73
24.48
15.56
10.58
12.03
30.18
44.3
Profit Margin (%)
-259
-1,088
-1,039
-813
-1,559
-1,603
-2,243
-2,100
-2,279
-3,640
-3,627
-4,409
-3,946
-3,472
-4,730
-3,165
-3,261
Working Capital
106
207
629
864
687
868
1,101
1,770
1,638
2,923
4,073
3,974
3,457
3,579
3,075
3,142
3,420
LT Debt
1,511
3,919
4,745
5,646
6,413
7,016
9,229
9,367
9,375
10,372
10,734
15,257
18,276
16,219
14,285
12,476
12,243
Total Equity
7.17
3.48
8.13
9.24
8.09
9.03
7.19
6.88
6.08
5.98
4.22
6.97
6.7
4.89
3.14
9.48
9.99
Return on Invested Capital (%)
9.17
4.01
5.59
5.95
5.81
6.39
5.12
5.98
5.03
5.02
2.97
8.43
4.89
3.52
3.39
8.54
9.61
Return on Capital (%)
10.77
5.8
11.55
13.8
13.04
14.5
11.23
12.58
10.25
10.86
5.83
17.74
10.08
6.34
5.75
14.71
17.6
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,303
4,089
4,125
LT Borrowings
3,064
2,849
3,338
LT Finance Leases
77
88
82
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13,485
13,485
13,485
Market Capitalization
18,879
18,879
18,474

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,489
2,055
2,085
Cash, Cash Equivalents & STI
1,655
1,177
1,144
Accounts Receivable, Net
261
214
269
Inventories
128
137
132
Total Current Liabilities
5,654
5,355
5,346
Payables & Accruals
964
881
848
ST Debt
4,303
4,089
4,125
Deferred Revenue
102
101
88

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.33%
5.22%
-12.66%
Free Cash Flow
-101.12%
-49.74%
-60.76%
Net Income, GAAP
32.28%
69.99%
142.61%
Sales/Revenue/Turnover
1.38%
0.37%
-3.29%
Total Cash Common Dividend
13.25%
18.87%
67.19%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,135
2,042
2,325
2,046
5,808
2025
1,405
1,345
2,109
-571
5,617
2026
1,337
1,294
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.01
0.03
-0.01
0.05
2025
- -
0.02
0.02
0.09
0.13
2026
0.01
0.02
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.06
- -
- -
0.06
2025
- -
0.06
0.03
0.02
0.1
2026
0.01
0.06
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Vibhavadi Medical Center Public Company Limited (VIBHA.BK) operates private hospitals and medical facilities in Thailand, providing comprehensive healthcare services through its flagship Vibhavadi Hospital and a network of subsidiaries and associates. The company offers inpatient and outpatient treatments across specialized centers and clinics, including pediatric diseases, general surgery, orthopedics, general medicine, women's health, gastroenterology, cardiology, neurology, brain tumor surgery, gamma knife radiosurgery, respiratory diseases, plastic surgery, ear-nose-throat, dental care, wellness and occupational health, LASIK, eye care, hemodialysis, dermatology, internal medicine, emergency services, infertility treatment, diabetes management, and cardiac care; it also provides vaccination services via Jab&Go clinics, anti-aging treatments at V Precision Clinic, aesthetic skincare and hair transplantation at V Design clinics, plastic surgery at V Surgery, fertility services at Fertiva Co., Ltd., room rentals, and health retail through Doctor's Choice stores. Founded in 1986 and headquartered at 51/3 Ngamwongwan Road, Latyao, Chatuchak, Bangkok, the company maintains operations primarily in the Bangkok metropolitan area, northern and eastern Thailand regions, serving patients under general, social security, and national health schemes through 258-350 beds at its main facility and affiliates such as Lanna Hospital (82.57% owned, 330 beds), Chiangmai Ram Hospital (46.54% owned, 220 beds), and associates including Vibharam Hospital Group (33.85% owned, 982 beds). Recent developments include the March 2025 launch of Fertiva Co., Ltd. as a standalone fertility clinic targeting international clients, the opening of V Surgery plastic surgery clinic in collaboration with W Plastic Surgery Hospital, establishment of Jab&Go vaccination clinics with MSD (Thailand) Co., Ltd. at BTS stations, plans for a Thai traditional medicine clinic with G Wellness Co., Ltd., anticipated Q3 2025 opening of SIAM GAMMA KNIFE THERAPY CENTER with Healthcare Therapeutics Co., Ltd. as Thailand's first such facility, ongoing construction of Vibhavadi Hospital Rama 2 branch (59 beds, targeted late 2025 or Q1 2026 with 1 billion baht budget), and completion of a share buyback program in September 2024 repurchasing 91.40 million shares for 194.23 million baht.